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Hypospadias is one of the most common 
  urogenital congenital anomalies affecting baby 
boys (Harris 1990). Prevalence estimates in 
Europe range from 4 to 24 per 10,000 births, 
depending on definition (Dolk et al. 2004), 
with higher rates reported from the United 
States (Paulozzi 1999). Since the 1960s, 
prevalence appears first to have increased, 
then stabilized, along with increasing trends 
among other male fertility-related disorders 
(Dolk et al. 2004; Toppari et al. 1996). Little 
is known about the etiology of hypospa-
dias. A role for endocrine-disrupting chemi-
cals (EDCs) has been proposed, specifically 
antiandrogens (Baskin et al. 2001). Animal 
studies suggest association of EDCs with vari-
ous disorders related to male fertility (Sharpe 
et al. 2003), but data on humans are largely 
lacking (Committee on Toxicity 2006). 
Studies of occupational risk factors have been 
inconclusive (Aho et al. 2003; Irgens 2000; 
Kallen 1988; Kristensen et al. 1997; Pierik 
et al. 2004; Vrijheid et al. 2003; Weidner 
et al. 1998). Concerning diet and vitamin 
use, few data are available on effects of folic 
acid supplementation/antagonists (Brouwers 
et al. 2007; Czeizel 1996; Czeizel et al. 2001), 
and two studies reported excess risk related to 
vegetarianism (Akre et al. 2008; North and 
Golding 2000). We report here results of a 
large population-based case–control study of 
hypospadias in southeast England with pri-
mary aims of investigating risk of hypospadias 
and a) maternal occupational exposures, spe-
cifically to EDCs; b) folic acid supplementa-
tion during pregnancy; and c) vegetarianism.
Data and Methods
The study region included the health regions 
of North Thames, South Thames, and the 
Anglian part of Anglia and Oxford (Figure 1), 
comprising 120 London boroughs and local 
authority districts. Surgical centers in the 
study region and major surgical centers within 
50 miles were visited. Hypospadias cases born 
in the study region over a 21-month period 
(1 January 1997–30 September 1998) were 
eligible if there was an abnormally positioned 
urethral orifice requiring surgery, with no 
major accompanying anomaly suggesting that 
it was part of a syndrome. Forty of 41 sur-
geons operating on hypospadias in the study 
region participated; 731 cases were identified 
from surgeons’ records and case notes. After 
initial contact by letter, up to two further 
invitations were sent. Of the 731 mothers, 
610 replied, of whom 471 (77%; 64% of 
total eligible cases) agreed to participate.
Controls born in the study region   during 
the same period as the cases were randomly 
selected from the birth registry by the Office 
for National Statistics (ONS; London, UK). 
Ethical approval was given by the West 
Midlands Multi-centre Research Ethics 
Committee, Birmingham, United Kingdom. 
Following guidelines from the ethics commit-
tee, ONS asked the health authorities (now 
primary care trusts) to contact the general 
practitioners (GPs) of the control children. 
The GPs were then asked to pass on the invi-
tation to the mother of the control child; in 
turn, the mothers were asked to contact the 
study team. In total, 1,568 control mothers 
were selected, but letters were not sent out to 
81 mothers. From the possible 1,487 invitees, 
there were 758 replies, of whom 490 (65%; 
33% of total eligible controls) agreed to take 
part. We attempted to contact a sample (n = 
200) of the 729 mothers who had not replied 
and found that 144 (72%) had not received 
an invitation, mainly because the GP had not 
passed on the information (73%); the fam-
ily had moved without a forwarding address 
(9·5%); or for other reasons. The cases and 
control mothers who agreed to participate 
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Ba c k g r o u n d: Hypospadias is one of the most common urogenital congenital anomalies affecting 
baby boys. Prevalence estimates in Europe range from 4 to 24 per 10,000 births, depending on defi-
nition, with higher rates reported from the United States. Relatively little is known about potential 
risk factors, but a role for endocrine-disrupting chemicals (EDCs) has been proposed.
OB j e c t i v e: Our goal was to elucidate the risk of hypospadias associated with occupational exposure 
of the mother to endocrine-disruptor chemicals, use of folate supplementation during pregnancy, 
and vegetarianism. 
De s i g n: We designed a case–control study of 471 hypospadias cases referred to surgeons and 490 
randomly selected birth controls, born 1 January 1997–30 September 1998 in southeast England. 
Telephone interviews of mothers elicited information on folate supplementation during pregnancy 
and vegetarianism. We used a job exposure matrix to classify occupational exposure.
Re s u l t s: In multiple logistic regression analysis, there were increased risks for self-reported occu-
pational exposure to hair spray [exposed vs. nonexposed, odds ratio (OR) = 2.39; 95% confidence 
interval (CI), 1.40–4.17] and phthalate exposure obtained by a job exposure matrix (OR = 3.12; 
95% CI, 1.04–11.46). There was a significantly reduced risk of hypospadias associated with of 
folate use during the first 3 months of pregnancy (OR = 0.64; 95% CI, 0.44–0.93). Vegetarianism 
was not associated with hypospadias risk. 
Co n c l u s i o n s: Excess risks of hypospadias associated with occupational exposures to phthalates and 
hair spray suggest that antiandrogenic EDCs may play a role in hypospadias. Folate supplementa-
tion in early pregnancy may be protective.
key w o r d s : endocrine disruptors, hair spray, folate supplementation, hypospadias, occupation. 
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were interviewed by telephone between 
September 2000 and March 2003.
Case and control mothers were inter-
viewed by telephone using a standard set 
of questions, with answers directly entered 
into a computer. The questionnaire included 
information on parental age, ethnicity, edu-
cation, household income; family history of 
disease; pregnancy history; and maternal occu-
pation, vegetarianism, folate supplements, 
smoking, alcohol use during pregnancy, and 
other questions related to diet history, vitamin 
use, demographics, and domestic and envi-
ronmental exposures to chemicals.
Approval for the study was obtained from 
the Multi-centre Research Ethics Committee 
and local research ethics committees in the 
study area, and participating mothers gave 
written consent before taking part in the study.
Occupational exposure to EDCs. To assess 
their occupational exposure to EDCs dur-
ing the first 3 months of pregnancy, mothers 
were asked about their job title, department, 
company, their five main tasks, possible expo-
sure to a list of 26 occupational substances 
(including hair spray, plastic fumes, cleaning 
agents such as disinfectants, solvents, paints 
and paint removers, printing ink, glue, heavy 
metal, welding and soldering fumes, anesthet-
ics, cytostatics and antibiotics, and pesticides), 
and the hours per week that they were in con-
tact with these exposures while at work. 
We used a job exposure matrix that 
included 348 possible job titles (Van Tongeren 
et al. 2002) to classify job title, department, 
company, and main tasks into seven exposure 
categories assessed by a panel of occupational 
hygienists as to the likelihood of exposure to 
EDCs (Van Tongeren et al. 2002). We then 
dichotomized exposure into either exposed  —
including possible and probable exposure—or 
unexposed, blind to case or control status. The 
classes of EDCs were pesticides, polychlori-
nated organic compounds, phthalates, alky-
lphenolic compounds, biphenolic compounds, 
heavy metals, and other (Baskin et al. 2001; 
Vrijheid et al. 2003). 
Statistical methods. We assessed corre-
lations between variables using Spearman’s 
and kappa statistics. Exposure prevalence for 
cases and controls and unadjusted odds ratios 
(ORs) and 95% confidence intervals (CIs) 
were calculated. Chi-square tests were used to 
test for statistical significance. 
We performed multiple logistic regression 
in the statistical package R (version 2.2.0; R 
Development Core Team 2005). Variables 
were included in the multiple regression if 
they were statistically significant (p < 0.05) 
in the univariate model and improved fit of 
the multiple logistic regression model using 
Akaike Information Criteria (Akaike 1974). 
Positive family history of hypospadias and 
previous stillbirth were excluded from the 
multiple logistic regression models because 
among the control participants there were 
only one and two with the specific risk fac-
tor respectively. p-Values are uncorrected for 
multiple comparisons. Because of multicolin-
earity (kappa = 0.82), maternal occupational 
exposure to hair spray and phthalates were 
not entered together in the multiple logistic 
regression models. Income or level of educa-
tion used to control for potential confounding 
by social class yielded similar findings; only 
models that included income are shown here. 
Table 1. Potential risk factors and confounders for hypospadias, unadjusted ORs, and 95% CIs. 
   Cases  Controls 
Characteristic  No. (%)  No. (%)   OR (95% CI)  p-Value
Maternal age (years)         0.080
  15–24  61 (13.1)  48 (9.8)  1.56 (1.02–2.41) 
  25–29  127 (27.2)  106 (21.6)  1.47 (1.06–2.05) 
  30–34a  165 (35.3)  203 (41.4)  1.00   
  35–39  95 (20.3)  109 (22.2)  1.07 (0.76–1.51) 
  40–50  19 (4.1)  24 (4.9)  0.97 (0.51–1.84) 
Ethnicity         0.520
  Nonwhitea  46 (9.8)  42 (8.6)  1.00 
  White  425 (90.2)  448 (91.4)  0.87 (0.56–1.34) 
Income         0.001
  < £10,000  56 (12.4)  29 (6.1)  2.74 (1.55–4.92) 
  £10,000 to < £20,000  130 (28.8)  110 (23.0)  1.68 (1.08–2.62) 
  £20,000 to < £30,000  127 (28.2)  131 (27.3)  1.38 (0.89–2.14) 
  £30,000 to £50,000  88 (19.5)  138 (28.8)  0.91 (0.58–1.42) 
  > £50,000a  50 (11.1)  71 (14.8)  1.00 
Gestational age        0.010
  Preterm (< 37 weeks)  54 (12.7)  34 (7.5)  1.79 (1.15–2.83) 
  Term (≥ 37 weeks)a  371 (87.3)  418 (92.5)  1.00 
Birth weight        0.010
  Low (< 2,500 g)  57 (13.8)  38 (8.5)  1.71 (1.11–2.66) 
  Normal (≥ 2,500 g)a  357 (86.2)  407 (91.5)  1.00 
Vegetarian/vegan        0.360
  Noa  390 (83.5)  394 (81.2)  1.00 
  Yes  77 (16.5)  91 (18.8)  0.85 (0.61–1.19) 
Maternal smokingb        0.020
  Noa  355 (75.5)  397 (81.7)  1.00 
  Yes  113 (24.0)  88 (18.1)  1.44 (1.05–1.97) 
Environmental tobacco smoke at home         0.050
  (0–12 weeks of pregnancy)      
  Noa  344 (74.6)  383 (80.5)  1.00 
  Yes  114 (24.7)  93 (19.5)  1.36 (1.00–1.86) 
Folate first 3 months during pregnancyc        0.010
  Noa  103 (21.9)  77 (15.8)  1.00 
  Yes  348 (74.0)  404 (82.8)  0.64 (0.46–0.89) 
aReference group. bTwo cases and one control stated “don’t know” in answer to the question. cNineteen cases and 
seven controls stated “don’t know” in answer to the question.
Figure 1. The study area and major National Health Service (NHS) hospitals operating on hypospadias in 
the southeast of England. Endocrine disruptors, hair spray, folate, and hypospadias
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We also examined multiple logistic regression 
models that included maternal age.
Results
Table 1 shows prevalence of various risk fac-
tors and potential confounders for hypos-
padias. Gestational age and birth weight 
were correlated (Spearman r = 0.41), as 
were income and maternal age (r = 0.33) 
and maternal smoking and environmental 
tobacco smoke (r = 0.31); no other correla-
tions exceeded ± 0.30. The hypospadias cases 
were more likely to be born preterm and to 
have low birth weight (< 2,500 g) (Table 1). 
Compared with mothers of control children, 
mothers of hypospadias cases tended to have 
lower income (p = 0.001), higher prevalence 
of smoking (p = 0.02), and lower prevalence 
of folate supplement use during the first 3 
months of pregnancy (p = 0.01) (i.e., the criti-
cal period for development of hypospadias) 
(Harris 1990). For these variables, unad-
justed ORs for the association with hypospa-
dias ranged from 1.44 (95% CI, 1.05–1.97) 
for smokers compared with nonsmokers, to 
2.74 (95% CI, 1.55–4.92) for household 
income < ₤10,000 compared with > ₤50,000, 
whereas folate supplementation during the 
first 3 months of pregnancy was associated 
with significantly reduced risk (OR = 0.64; 
95% CI, 0.46–0.89) (Table 1). There was 
no association with vegetarianism (p = 0.36). 
Positive family history of hypospadias and 
previous stillbirth were also significantly asso-
ciated with risk of hypospadias (not shown). 
Among occupational exposures (preva-
lence ≥ 5%), significantly increased risk was 
found for self-reported exposure to hair spray 
(exposed vs. nonexposed unadjusted OR = 
2.30; 95% CI, 1.38–3.89) (Table 2). With 
the job exposure matrix, exposure prevalences 
were all < 5%; significant excess risk of hypos-
padias was found for boys of mothers exposed 
to phthalates (including hairdressers, beauty 
therapists/those working in beauty/ hairdress-
ing, research chemists, line operators, phar-
maceutical operators, electrical assemblers, 
factory assistants) compared with those with 
no exposure to phthalates at work (unadjusted 
OR = 3.65; 95% CI, 1.19–11.20; 14 cases, 
4 controls). 
After adjustment for multiple potential 
confounders, the significant positive associa-
tion with maternal occupational exposure to 
hair spray was slightly strengthened (exposed 
vs. unexposed OR = 2.39; 95% CI, 1.40–4.17) 
(Table 3). Hairdressers as a group had a 
nonsignificant increased risk (unadjusted 
OR = 2.73; 95% CI, 0.72–10.38; adjusted 
OR = 2.59; 95% CI, 0.70–12.32). Folate 
supplementation during the first 3 months 
of pregnancy remained inversely associated 
with risk of hypospadias, with a virtually 
unchanged risk estimate (OR = 0.64; 95% 
CI, 0.44–0.93). With phthalates included in 
the model instead of occupational exposure to 
hair spray, the risk estimates for folate supple-
mentation and other factors remained essen-
tially unchanged; occupational phthalates 
exposure was associated with 3-fold elevated 
risk (OR = 3.12, 95% CI, 1.04–11.46) (Table 
3). Inclusion of maternal age did not materi-
ally alter the risk estimates for the other vari-
ables in the model (data not shown).
Table 2. Exposure prevalence, unadjusted ORs, and 95% CIs for self-reported maternal occupational 
exposure among employed women (for substances with an exposure prevalence > 5%) and unemployed 
women. 
   Cases  Controls 
Exposure  No. (%)  No. (%)  OR (95% CI)  p-Value 
Hair spray         0.004
  Not exposeda  294 (63.0)  324 (67.8)  1.00 
  Exposedb  50 (10.7)  24 (5.0)  2.30 (1.38–3.89) 
  Unemployed  123 (26.3)  130 (27.2)  1.04 (0.78–1.40) 
Cleaning agents         0.480
  Not exposeda  233 (49.9)  250 (52.30)  1.00 
  Exposedb  111 (23.8)  98 (20.5)  1.22 (0.88–1.68) 
  Unemployed  123 (26.3)  130 (27.2)  1.02 (0.75–1.38) 
Printing ink         0.810
  Not exposeda  282 (60.4)  291 (60.9)  1.00 
  Exposedb  62 (13.3)  57 (11.9)  1.12 (0.76–1.67) 
  Unemployed  123 (26.3)  130 (27.2)  0.98 (0.73–1.31) 
Glue         0.290
  Not exposeda  313 (67.0)  304 (63.6)  1.00 
  Exposedb  31 (6.6)  44 (9.2)  0.68 (0.42–1.11) 
  Unemployed  123 (26.3)  130 (27.2)  0.92 (0.69–1.23) 
Exhaust fumes         0.950
  Not exposeda  295 (63.2)  299 (62.6)  1.00 
  Exposedb  49 (10.5)  49 (10.3)  1.01 (0.66–1.56) 
  Unemployed  123 (26.3)  130 (27.2)  0.96 (0.71–1.29) 
Grain, hay, paper, and textile dust       0.650
  Not exposeda  313 (67.0)  323 (67.6)  1.00 
  Exposedb  31 (6.6)  25 (5.2)  1.28 (0.74–2.23) 
  Unemployed  123 (26.3)  130 (27.2)  0.98 (0.73–1.31) 
Dust         0.340
  Not exposeda  273 (58.5)  291 (60.9)  1.00 
  Exposedb  71 (15.2)  57 (11.9)  1.33 (0.90–1.96) 
  Unemployed  123 (26.3)  130 (27.2)  1.01 (0.75–1.36) 
Model estimates based on data for 371 cases and 419 controls. 
aEmployed women not occupationally exposed. bEmployed women occupationally exposed. 
Table 3. Multiple regression modelsa of hypospadias:adjusted ORs and 95% CIs.
Variable  Adjusted OR (95% CI)  p-Value
Income    0.003
  < £10,000  2.92 (1.49–5.85) 
  £10,000 to < £20,000  1.59 (0.97–2.61) 
  £20,000 to < £30,000  1.52 (0.94–2.48) 
  £30,000 to £50,000  0.99 (0.60–1.64) 
  ≥ £50,000  1.00 
Birth weight    0.010
  Low (< 2,500 g)  1.87 (1.18–2.98) 
  Normal (≥ 2,500 g)  1.00 
Maternal smoking    0.270
  No  1.00 
  Yes  1.22 (0.85–1.76) 
Folate during first 3 months of pregnancy    0.020
  No  1.00 
  Yes  0.64 (0.44–0.93) 
Maternal occupational exposure to hair spray    0.004
  No  1.00 
  Yes  2.39 (1.40–4.17) 
  Unemployed  0.97 (0.69–1.37) 
Or   
Maternal occupational exposure to phthalates    0.100
  No  1.00 
  Yes  3.12 (1.04–11.46) 
  Unemployed  0.91 (0.65–1.28) 
aEstimates for income, birth weight, maternal smoking, and folate supplementation are for the model that includes self-
reported exposure to hair spray (model fit Akaike Information Criterion 1066). Estimates are essentially unchanged with 
inclusion instead of maternal occupational exposure to phthalates (model fit Akaike Information Criterion 1072). Ormond et al.
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Discussion
In this large case–control study, we found 2- 
to 3-fold increased risk of hypospadias among 
children of mothers exposed to hair spray 
and phthalates in the workplace during preg-
nancy and a 36% reduction in risk associated 
with folate supplementation during the first 
3 months of pregnancy. These findings were 
robust to control for potential confounders. 
In contrast with two smaller studies (Akre 
et al. 2008; North and Golding 2000), we 
did not find an association between vegetari-
anism/veganism and hypospadias. 
This is the first study to report a significant 
association between maternal occupational 
exposure to hair sprays, some of which may 
contain phthalates, and risk of hypospadias. 
A previous study reported that from 1980 to 
1989, women hairdressers had slightly reduced 
risk of giving birth to a boy with hypospa-
dias, whereas during 1992–1996, risk was 
significantly increased (OR = 1.50; 95% CI, 
1.02–2.09) (Vrijheid et al. 2003). The risk was 
reduced after adjustment for parental social 
class (OR = 1.18; 95% CI, 0.80–1.64), sug-
gesting possible confounding (Vrijheid et al. 
2003). In contrast, our study showed that 
adjustment for household income (or maternal 
educational level) as a proxy for social class did 
not materially affect the risk estimates. 
We are unaware of studies that have 
reported urinary phthalate metabolites in 
hairdressers or women applying hair sprays, so 
it is unclear to what extent their exposure may 
have been elevated at the time of the study. 
Phthalates, predominantly diethyl phthalate 
(DEP) and dibutyl phthalate (DBP), were 
present in many cosmetics including deodor-
ants, fragrances, and nail and hair products 
(Hubinger and Havery 2006; Koo and Lee 
2004). However, since 2005, certain phtha-
lates including DBP have been prohibited 
for use in cosmetic products in Europe. The 
phthalates or their metabolites, for example, 
monoethyl phthalate and mono-n-butyl 
phthalate, are associated with androgen-
lowering activities and abnormal Leydig cell 
function and have been linked to a decrease 
in anogenital distance in male infants (Main 
et al. 2006; Swan et al. 2005); androgen 
lowering is associated with reproductive 
tract malformations including hypospadias 
(Lottrup et al. 2006; Mylchreest et al. 2000, 
2002). Inhalation contributes significantly to 
the uptake of these phthalates (Adibi et al. 
2003), which may explain some species dif-
ferences for DEP between human and animal 
studies, where oral administration has mainly 
been used (Lottrup et al. 2006; Mylchreest 
et al. 2000, 2002). A number of other sub-
stances included in hair sprays may have toxic 
effects if inhaled. They include polyvinyl 
alcohol, polyvinylpyrolidone, hydrofluoro-
carbon, and propylene glycol, although for 
these substances the concern is acute effects 
on the cardiorespiratory system, skin, and 
eyes rather than on the reproductive system 
(U.S. National Library of Medicine 2008). 
This is also the first study to show a pro-
tective effect of folate supplementation on risk 
of hypospadias. A recent Dutch case–control 
study found no association of maternal folic 
acid supplements and hypospadias (Brouwers 
et al. 2007), nor was there an effect in a trial 
of folic acid/multivitamin supplementation 
based on small numbers of cases (Czeizel 
1996). However, in a Hungarian case–control 
study, use of dihydrofolate reductase inhibi-
tors (folic acid antagonists) in pregnancy was 
associated with a (nonsignificant) 20% excess 
risk of hypospadias (Czeizel et al. 2001). 
Although we cannot exclude recall bias in 
our study, we believe it is unlikely to explain 
our findings, given that folate has not previ-
ously been associated with hypospadias, and, 
to explain the association reported here, the 
size of any such bias would need to be large. 
In the United Kingdom, 400 µg folate supple-
mentation is recommended in the first trimes-
ter of pregnancy for the prevention of neural 
tube defects (Department of Health 2000). 
Although we did not collect quantitative data 
on dietary intake of folate, the National Diet 
and Nutrition Survey estimated that mean 
intake of folate from foods ranged from 229 µg/
day for women at 19–24 years of age to 255 µg/
day at 35–49 years of age (National Diet and 
Nutrition Survey 2003). Thus, folate supple-
mentation is likely to have more than doubled 
the daily folate intake. Like the neural tube, 
the urethra is a midline structure. Biochemical, 
genetic, and epidemiologic observations suggest 
that folic acid may prevent neural tube defects 
by stimulating cellular methylation reactions, 
although this methylation hypothesis requires 
further exploration (Blom et al. 2006). Folic 
acid may also protect against other congeni-
tal anomalies such as orofacial clefts, cardiac, 
and urinary tract defects (Hernandez-Diaz et al. 
2000). In addition, recall bias for hair spray 
is unlikely, because only one previous study 
reported a possible association (Vrijheid et al. 
2003). Recall bias is not an issue for phthalate 
exposure, because it was assessed by job expo-
sure matrix. However, some exposure misclassi-
fication is possible with the job exposure matrix 
because of uncertainty in expert assessment 
(Van Tongeren et al. 2002).
Of other potential risk factors for hypospa-
dias, some studies have suggested associations 
with occupational exposures of the father, 
including vehicle mechanics and exposure 
to solvents (Irgens 2000; Pierik et al. 2004). 
In our study we did not collect information 
on occupation of the father. Family history 
(Angerpointner 1984; Brouwers et al. 2007; 
Hernandez-Diaz et al. 2000; Kallen et al. 
1986; Neto et al. 1981) and low birth weight 
(Angerpointner 1984; Kallen et al. 1986; 
Neto et al. 1981) have also been reported. 
Although possible associations with mater-
nal smoking are inconsistent (Angerpointner 
1984; Brouwers et al. 2007; Carmichael et al. 
2005; Kallen 1997), recent reports suggest 
that if the father smoked, there was a higher 
risk of a boy being born with hypospadias 
than if the mother smoked (Pierik et al. 
2004), implying that environmental tobacco 
smoke (ETS) may play a part. In unadjusted 
analysis we found a borderline significant 
increased risk associated with ETS. 
Major strengths of our study include the 
large sample size, wide population-based cover-
age, and extensive interviewer-based question-
naire. Most previous studies of hypospadias 
have relied on routinely collected registry data 
with limited information on potential risk fac-
tors and confounders, and varying levels of 
quality control and completeness (Aho et al. 
2003; Irgens 2000; Kallen 1988; Kallen et al. 
1986; Kristensen et al. 1997; Vrijheid et al. 
2003). We ascertained slightly more cases than 
the hospital registries and many more cases 
than the national congenital anomalies system 
(Nelson et al. 2007). Our study also has limita-
tions. One potential weakness is the low pro-
portion of control women who replied to our 
invitation to participate. Because of constraints 
imposed by the ethics committee, we were not 
able to contact the women in the control group 
directly after they were randomly selected from 
the birth registry. Instead, we had to follow a 
convoluted procedure requiring both health 
authorities and the mothers’ GPs to forward 
our invitation pack, with the result that an esti-
mated 72% of nonresponders never received 
the participant invitations. Although the con-
trols appeared to be of slightly higher social 
class than the cases, adjusting for socioeco-
nomic status (i.e., income or education) made 
no difference to our findings. 
Furthermore, we investigated more for-
mally the potential for selection bias by socio-
economic status (SES) in selection of cases 
and controls using a weighting procedure 
analogous to poststratification for adjustment 
of item nonresponse in the survey literature 
(Park et al. 2004). In brief, this involves 
reweighting the estimates of probabilities of 
exposure conditional on case/control status 
according to the distribution of SES in the 
target (i.e., unbiased population). The idea is 
that if, for example, individuals with low SES 
are underrepresented in the study, these esti-
mates can be up-weighted using the SES dis-
tribution of the target population. We found 
no evidence of selection bias mediated by SES 
in the study (Geneletti et al. 2008).
A particular difficulty affecting research on 
hypospadias is the wide variation in case defi-
nition, from mild displacement of the urethral 
orifice to severe anomalies requiring major Endocrine disruptors, hair spray, folate, and hypospadias
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corrective surgery (Baskin et al. 2001). We 
relied on clinical judgment of surgeons who 
operate on cases, and thus excluded milder 
cases who were not referred for surgical cor-
rection. We also excluded cases where hypos-
padias was part of a wider syndrome. Thus 
our study is likely to have included a greater 
proportion of more severe, isolated cases than 
some previous studies. 
In conclusion, this is the first study to 
report increased risks of hypospadias associated 
with exposure to phthalates and hair sprays 
and a protective effect of folate supplemen-
tation. Previous association of vegetarianism 
with risk of hypospadias was not confirmed. 
Measurements of exposure to phthalates and/
or biomonitoring may help to understand pos-
sible pathways of exposure and toxicology and 
provide quantitative estimates. Our findings 
with respect to folate use may have important 
implications for public health and prevention.
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